Clones: 1G8.1, 2E11, 3E3.1, and GAM2.1 (BBP2020SP, BBP2019SP, BBP2018SP, and BBP2021SP respectively) Monoclonal antibodies against IFN-gamma. Preliminary experiments show clones 2E11 and 3E3.1 may function to neutralize IFN gamma. IFN-gamma is produced by lymphocytes activated by specific antigens or mitogens. In addition to having antiviral activity, IFN-gamma has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons.
Trial Pack of Four Interferon Gamma Monoclonal Antibodies, Size: 25 µg each
Tested Applications: ELISA/WESTERN, Preliminary experiments show clones 2E11 and 3E3.1 may function to neutralize IFN gamma.
Target Information: Interferon gamma is a 19.22kDa immuno-regulatory cytokine.
Product Format: Affinity Purified, 1 mg/ml in Phosphate Buffered Saline. Aseptically Packaged.
Alternate Names: Interferon gamma, IFN gamma
Clones: 1G8.1, 2E11, 3E3.1, GAM2.1
Immunogen: Recombinant Protein
Specificity: Human IFN-gamma
This product contains the equivalent of trial sizes of Neoclone Catalog #s N0009, N0010, N0011, and N0012 or BioLegend Catalog #s 526502, 526602, 526702, and 526802.